FDA rule may aid drug firms in liability suits
Curbs to preempt state requirements on label warnings
A new rule issued by the Food and Drug Administration yesterday to make cryptic drug labels easier to read also preempts state laws that conflict with the agency's stance on drug warnings, aiding manufacturers in some liability lawsuits. (Full article: 659 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
